These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 4139751)
1. Oestrogenic treatment of prostatic cancer lowers the fibrinolytic activity in vein walls. Carlsson S; Astedt B Scand J Urol Nephrol; 1974; 8(3):169-72. PubMed ID: 4139751 [No Abstract] [Full Text] [Related]
2. Experimental and clinical studies on the thrombin-like enzyme from the venom of Bothrops atrox. On the primary structure of fragment E. Egberg N Acta Physiol Scand Suppl; 1973; 400():1-47. PubMed ID: 4599946 [No Abstract] [Full Text] [Related]
3. The fibrinolytic enzyme system in acute and chronic liver injury. Mowat NA; Brunt PW; Ogston D Acta Haematol; 1974; 52(5):289-93. PubMed ID: 4141562 [No Abstract] [Full Text] [Related]
4. 17-beta-oestradiol and the fibrinolytic activity on vein walls. Astedt B; Jeppsson S J Obstet Gynaecol Br Commonw; 1974 Sep; 81(9):719-23. PubMed ID: 4138043 [TBL] [Abstract][Full Text] [Related]
5. The effect of clofibrate on components of the fibrinolytic enzyme system. Ogston D; Bennett NB; Crawford GP; Douglas AS Atherosclerosis; 1972; 16(2):273-6. PubMed ID: 4117793 [No Abstract] [Full Text] [Related]
7. Oestrogens and blood coagulation. von Kaulla KN Triangle; 1976; 15(1):9-17. PubMed ID: 785733 [No Abstract] [Full Text] [Related]
8. Biochemical evaluation of low dose of urokinase in acute myocardial infarction. A double-blind study. Gormsen J; Tidstrom B; Feddersen C; Ploug J Acta Med Scand; 1973; 194(3):191-8. PubMed ID: 4583532 [No Abstract] [Full Text] [Related]
9. Fibrinolytic activity of veins in the puerperium. Astedt B Acta Obstet Gynecol Scand; 1972; 51(4):325-8. PubMed ID: 4642719 [No Abstract] [Full Text] [Related]
10. Activators and inhibitors of coagulation and fibrinolysis in patients with prostatic cancer treated with oestrogen or orchidectomy. Henriksson P; Blombäck M; Bratt G; Edhag O; Eriksson A Thromb Res; 1986 Dec; 44(6):783-91. PubMed ID: 3798420 [TBL] [Abstract][Full Text] [Related]
11. Pattern of the activator inhibitor in carcinoma and renal diseases. Hedner U; Nilsson IM Scand J Haematol; 1973; 11(5):398-404. PubMed ID: 4798342 [No Abstract] [Full Text] [Related]
12. Fibrin formation and dissolution in women receiving oral contraceptive drugs. Ball AP; McKee PA J Lab Clin Med; 1977 Apr; 89(4):751-62. PubMed ID: 845477 [TBL] [Abstract][Full Text] [Related]
13. Fibrinolysis and coagulation. Effect of calcium and of coagulation on the lysis of fibrin clots. Helle I Scand J Haematol Suppl; 1968; 4():1-46. PubMed ID: 4181525 [No Abstract] [Full Text] [Related]
14. Coagulation, clot lysis, and thrombosis. I. Acid-labile inhibitor of fibrinolysis in rats fed thrombogenic diets. Sisson JA; Lee KT; Jadick PF; Thomas WA Exp Mol Pathol; 1968 Apr; 8(2):159-70. PubMed ID: 4231027 [No Abstract] [Full Text] [Related]
15. Studies on the blood fibrinolytic system in congestive cardiac failure. Rawles JM; Ogston D; Douglas AS Clin Sci; 1973 Jul; 45(1):65-76. PubMed ID: 4124172 [No Abstract] [Full Text] [Related]
16. Effect of venous occlusion on coagulation and fibrinolytic components in normal subjects. Nilsson IM; Robertson B Thromb Diath Haemorrh; 1968 Dec; 20(3):397-408. PubMed ID: 5710462 [No Abstract] [Full Text] [Related]
17. Fibrinolytic activity of veins during treatment with medroxyprogesterone acetate. Astedt B Acta Obstet Gynecol Scand; 1972; 51(3):283-6. PubMed ID: 4561175 [No Abstract] [Full Text] [Related]
18. Effect of treatment with combined phenformin and ethyloestrenol on the coagulation and fibrinolytic systems. Nilsson IM; Isacson S J Clin Pathol; 1972 Jul; 25(7):638-9. PubMed ID: 5070268 [No Abstract] [Full Text] [Related]
19. Coagulative and fibrinolytic studies on postmenopausal women treated with a new non-steroidal oestrogen. Kullander S; Svanberg L; Astedt B Acta Obstet Gynecol Scand; 1977; 56(4):371-4. PubMed ID: 74933 [TBL] [Abstract][Full Text] [Related]
20. Studies on the thrombin clotting time. II. The influence of fibrin degradation products. Arnesen H Scand J Haematol; 1973; 10(4):291-7. PubMed ID: 4764611 [No Abstract] [Full Text] [Related] [Next] [New Search]